HomeInherit is a financial services and real estate company focused on providing senior homeowners with equitable access to home-based liquidity while maintaining residency security. Its team combines ...

Jefferies, BofA Securities, Guggenheim Securities and TD Cowen acted as joint book-running managers for the offering. BTIG acted as passive bookrunner for the offering.

Kushykush guarantees a personalized and efficient experience, both in-store and online. To support customer privacy, deliveries are made in an unmarked car by a professional driver, looking just like ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on October 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...

PIPE financing included participation from leading healthcare-focused institutional investors including AIGH Capital Management, Soleus Capital, Nantahala Capital, Diadema Partners, Stonepine Capital ...

Gloria Sheynkman, PhD, Assistant Professor, University of Virginia School of Medicine, will discuss how proteomic profiling identified isoform-specific biomarkers predicting survival differences in ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it will have a ...

Part of that process was attending the ECRM buyers conference held in Palm Beach Gardens, Florida. From September 8th through the 10th, the Korean brand brought its flagship trio of products to the ...

AB Science SA (Euronext - FR0010557264 - AB) today announces its half-year financial results as of June 30, 2025, and provides an update on its activities.

The aggregate gross proceeds to the Company from the offering are expected to be approximately $6 million, before deducting the placement agent fees and other offering expenses payable by the Company.

WHAT: An Inconvenient Study is an ICAN and Del Bigtree Film. Through shocking hidden camera footage, expert interviews, and archival footage, the film challenges long-held assumptions about vaccine ...

With CAP accreditation secured, YD Bio and EG BioMed are well positioned to expand their diagnostic portfolio, focusing on early cancer detection and monitoring. Along with YD Bio’s ophthalmology ...